Amgen Inc. lost requests for several judgments in Lindis Biotech GmbH’s patent-infringement lawsuit seeking damages for sales of the leukemia treatment Blincyto, according to a federal judge’s mixed ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

Senior Gwen Eichfeld, captain of the Colgate University women’s ice hockey team, goes above and beyond in her role as a ...

BMO Capital analyst Evan Seigerman has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

Novartis forecasts delayed blood-cancer drug launches while Amgen anticipates crucial weight-loss drug data. Additionally, Neuralink has advanced its brain chip trials in Canada. Political dynamics ...

Lowering BMI alone may reduce the risk of various obesity-related diseases, but other factors might also play a role. A new ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Some industry leaders are confident health care products such as drugs will be carved out of expected Trump administration tariffs ...